The IVS6 segment of the L-type calcium channel is critical for the action of dihydropyridines and phenylalkylamines

被引:112
作者
Schuster, A
Lacinova, L
Klugbauer, N
Ito, H
Birnbaumer, L
Hofmann, F
机构
[1] SLOVAK ACAD SCI, INST MOLEC PHYSIOL & GENET, BRATISLAVA 83304, SLOVAKIA
[2] UNIV CALIF LOS ANGELES, SCH MED, DEPT ANESTHESIOL, LOS ANGELES, CA 90024 USA
关键词
channel agonist; dihydropyridines; L-type calcium channel; phenylalkylamines;
D O I
10.1002/j.1460-2075.1996.tb00592.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The current through the L-type calcium channel is inhibited and stimulated by distinct dihydropyridines at very low concentrations. The molecular determinants for the high affinity block and stimulation were investigated using chimeras between the class C and E calcium channels. Mutation of three amino acids in the last putative transmembrane segment (IVS6) of the alpha(1C) subunit decreased the affinity for (+)isradipine 100-fold without significantly affecting the basic properties of the expressed channel, Mutation of two of these three amino acids completely abolished the stimulatory effect of the calcium channel agonist Bay K 8644. These mutations only slightly affected the blocking efficacy of mibefradil and the phenylalkylamine devapamil, Three distinct but adjacently located amino acids mediated the high affinity block by devapamil. These results suggest that the IVS6 segment of the alpha(1C) subunit is critical for the high affinity interaction between the L-type calcium channel and the calcium channel agonist Bay K 8644 and the two antagonists isradipine and devapamil.
引用
收藏
页码:2365 / 2370
页数:6
相关论文
共 30 条
[1]  
BANGALORE R, 1994, MOL PHARMACOL, V46, P660
[2]   NITRENDIPINE BLOCK OF CARDIAC CALCIUM CHANNELS - HIGH-AFFINITY BINDING TO THE INACTIVATED STATE [J].
BEAN, BP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (20) :6388-6392
[3]   THE MOLECULAR-MODE OF ACTION OF THE CA AGONIST (-) BAY K-8644 ON THE CARDIAC CA CHANNEL [J].
BECHEM, M ;
HOFFMANN, H .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1993, 424 (3-4) :343-353
[4]  
BEZPROZVANNY L, 1995, MOL PHARMACOL, V48, P540
[5]   PRIMARY STRUCTURE AND FUNCTIONAL EXPRESSION OF A HIGH-VOLTAGE ACTIVATED CALCIUM-CHANNEL FROM RABBIT LUNG [J].
BIEL, M ;
RUTH, P ;
BOSSE, E ;
HULLIN, R ;
STUHMER, W ;
FLOCKERZI, V ;
HOFMANN, F .
FEBS LETTERS, 1990, 269 (02) :409-412
[6]   RECEPTOR-SITES FOR CA2+ CHANNEL ANTAGONISTS [J].
CATTERALL, WA ;
STRIESSNIG, J .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1992, 13 (06) :256-262
[7]   [H-3] VERAPAMIL BINDING-SITES IN SKELETAL-MUSCLE TRANSVERSE TUBULE MEMBRANES [J].
GALIZZI, JP ;
FOSSET, M ;
LAZDUNSKI, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 118 (01) :239-245
[8]  
GALIZZI JP, 1986, J BIOL CHEM, V261, P1393
[9]   MODULATION OF CALCIUM CHANNELS IN ARTERIAL SMOOTH-MUSCLE CELLS BY DIHYDROPYRIDINE ENANTIOMERS [J].
HERING, S ;
HUGHES, AD ;
TIMIN, EN ;
BOLTON, TB .
JOURNAL OF GENERAL PHYSIOLOGY, 1993, 101 (03) :393-410
[10]   DIFFERENT MODES OF CA-CHANNEL GATING BEHAVIOR FAVORED BY DIHYDROPYRIDINE CA-AGONISTS AND ANTAGONISTS [J].
HESS, P ;
LANSMAN, JB ;
TSIEN, RW .
NATURE, 1984, 311 (5986) :538-544